Terumo announces first implant of Thoracoflo

Terumo Aortic recently announced the first implant of its custom-made thoracoabdominal hybrid device Thoracoflo in North America.

Dr Randy Moore, co-director of the Calgary Complex Aortic Program at the University of Calgary in Canada, performed the first thoracoabdominal repair procedure using Thoracoflo. The University of Calgary team, led by Moore, received support from Professor Sabine Wipper, chair of vascular Surgery at University Hospital Innsbruck in Austria. Wipper has been a key contributor to the development of the device, according to the company.

“This unique hybrid graft was designed through Terumo Aortic’s custom device program, specifically for the patient we were treating. With no other device with similar technology currently available globally for thoracoabdominal aortic repair, the Thoracoflo graft is designed to reduce the risk of complications associated with thoracotomy and extracorporeal circulation,” Moore said. “This is the first time the device has been implanted in North America; it was easy to implant, and the procedure was uneventful and straightforward. The patient is recovering well with no complications post-operatively.”

Thoracoflo uses a combination of Term Aortic’s Gelweave woven polyester grafts and unique ring-stent technology to address a patient’s specific anatomy.

“This expansion into North America represents a significant commitment to developing patient specific solutions to treat a wider group of patients as part of our comprehensive surgical, endovascular and hybrid portfolio,” Terumo Aortic Chief Technology and Marketing Officer John Canning said in a news release. MassDevice